cache/1b65163029b0137ff67e285942e1bf500e75d2192c286b535e1ad45958ed56ca

BIO:TOME

Tome Biosciences

  • Privately Held

Tome Biosciences is a biotechnology company that develops programmable gene insertion technology using CRISPR, allowing the insertion of any genetic sequence of any size at any location into any genome. The company focuses on cell and integrative gene therapies for patient care.

investor of